Processing...
Processing...
Inmagic
®
Presto
Version 5.5 Build 151
Inmagic
®
Presto
Copyright © 2005-2021 by Lucidea Technologies Corp., Richmond BC Canada. All rights reserved.
Inmagic® and the Inmagic logo are registered trademarks of Lucidea Technologies Corp.
Unauthorized duplication or distribution is prohibited.
Other brand and product names are trademarks or registered trademarks of their respective holders. Use of any other product name does not imply endorsement of that product by Inmagic.
Third-party Licenses
Processing...
Processing...
Title
Olanzapine and Autism
Author
Research Autism
Summary
This online article describes and evaluates olanzapine, an antipsychotic medication used to treat symptoms of schizophrenia and bipolar disorder. The medication is sometimes used to treat challenging behaviors by people on the autism spectrum.
The article notes that there is some very limited, short-term evidence to suggest that olanzapine can be useful in treating behavior issues in people on the autism spectrum. However, the article notes that the medication is associated with many possible side effects, probably including even more weight gain than from other atypical antipsychotics. The article therefore suggests that olanzapine should not be used as a first choice.
Research Autism was a charity funding research in autism interventions. Research Autism’s information services have been absorbed by the National Autistic Society (NAS). Founded in 1962, the NAS “provide[s] information, support and pioneering services, and campaign[s] for a better world for autistic people. [Website]
Language
English
Subjects
Health
Publisher
Research Autism
DateModified
9/22/2022 3:21 PM EDT